AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 84 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $41,000 | -45.3% | 7,860 | 0.0% | 0.00% | – |
| Q4 2015 | $75,000 | -26.5% | 7,860 | -36.3% | 0.00% | – |
| Q3 2015 | $102,000 | -43.3% | 12,335 | +11.2% | 0.00% | – |
| Q2 2015 | $180,000 | +2.9% | 11,088 | +157.4% | 0.00% | – |
| Q1 2015 | $175,000 | -94.0% | 4,307 | -92.0% | 0.00% | -100.0% |
| Q4 2014 | $2,910,000 | +58.9% | 53,878 | +0.6% | 0.00% | +50.0% |
| Q3 2014 | $1,831,000 | – | 53,553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|